KFF Health News 46d ago

In one of the most widely expected departures in recent memory, Marty Makary stepped down as head of the FDA this week. Meanwhile, the Supreme Court is considering blocking telehealth prescriptions for the abortion pill mifepristone. Lauren Weber of The Washington Post, Alice Miranda Ollstein of Politico, and Rachel Cohrs Zhang of Bloomberg News join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Sen. Tammy Baldwin (D-Wis.) about health issues before Congress. Chapters: 00:00 - Introduction 00:53 - FDA Commissioner Is Out 05:48 - Tobacco and MAHA 07:28 - Former Corporate Lawyer Now Acting FDA Leader 09:37 - Senate Nominations Stacking Up 11:07 - SCOTUS Delays Ruling on Telehealth Abortion Pill 13:42 - Anti-Abortion Groups are Unhappy 15:15 - Debut of Moms.gov 17:18 - U.S. Owes $600 Million to Global Vaccine Group 19:07 - Hantavirus Quarantine in Nebraska 23:53 - Senator Tammy Baldwin 35:42 - Extra Credits